Sign in →

Test Code QNADL Adalimumab Quantitative, Serum


Specimen Required


Only orderable as part of profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

Patient Preparation: For 12 hours before specimen collection, it is recommended that the patient not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial


Useful For

Therapeutic drug monitoring of adalimumab concentration

Testing Algorithm

When this test is ordered, adalimumab quantitation and testing for antibodies to adalimumab will always be performed. 

Method Name

Only orderable as part of a profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

Enzyme-Linked Immunosorbent Assay (ELISA)

Reporting Name

Adalimumab QN, S

Specimen Type

Serum

Specimen Minimum Volume

0.35 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 28 days
  Frozen  28 days

Reference Values

Only orderable as part of profile. For more information see ADALP / Adalimumab Quantitative with Antibody, Serum.

 

ADALIMUMAB QUANTITATIVE:

Limit of quantitation is 0.8 mcg/mL. Optimal therapeutic ranges are disease specific.

Day(s) Performed

Monday, Wednesday, Friday

Report Available

2 to 4 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

80145

LOINC Code Information

Test ID Test Order Name Order LOINC Value
QNADL Adalimumab QN, S 86894-3

 

Result ID Test Result Name Result LOINC Value
QNADL Adalimumab QN, S 86894-3